Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes - Archive ouverte HAL Access content directly
Journal Articles International Journal of Antimicrobial Agents Year : 2021

Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes

(1, 2) , (1, 2) , (2, 3) , (2, 3)
1
2
3

Dates and versions

hal-03216101 , version 1 (03-05-2021)

Identifiers

Cite

Philippe Gautret, van Thuan Hoang, Jean-Christophe Lagier, Didier Raoult. Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes. International Journal of Antimicrobial Agents, 2021, 57 (1), pp.106239. ⟨10.1016/j.ijantimicag.2020.106239⟩. ⟨hal-03216101⟩
19 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More